APPLIED GENETIC TECHNOLOGIES CORP Annual Net Cash Provided by (Used in) Investing Activities in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Applied Genetic Technologies Corp quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2016 to 2022.
  • Applied Genetic Technologies Corp Net Cash Provided by (Used in) Investing Activities for the quarter ending September 30, 2022 was -$304K, a 122% decline year-over-year.
  • Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$14K.
  • Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Investing Activities for 2021 was $38.1M, a 354% increase from 2020.
  • Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Investing Activities for 2020 was $8.4M, a 55.9% decline from 2019.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$14K* -$38.2M Jul 1, 2021 Jun 30, 2022 10-K 2022-09-27
2021 $38.1M +$29.7M +354% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-27
2020 $8.4M -$10.6M -55.9% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-23
2019 $19M -$14M -42.4% Jul 1, 2018 Jun 30, 2019 10-K 2020-09-18
2018 $33M +$204K +0.62% Jul 1, 2017 Jun 30, 2018 10-K 2019-09-26
2017 $32.8M +$134M Jul 1, 2016 Jun 30, 2017 10-K 2018-09-11
2016 -$101M Jul 1, 2015 Jun 30, 2016 10-K 2018-09-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.